PhillyVoice interviewed Silvia Fossati, PhD, Associate Professor of Neural Sciences and Interim Director of the Alzheimer’s Center at the Lewis Katz School of Medicine at Temple University, about a new animal study published in the journal Cell which found Zolpidem, the sedative in Ambien and other sleep drugs, may adversely affect a brain function believed to be key in preventing dementia. Dr. Fossati was not involved in the study.